Top compounds associated with response to CTD-2521M24.13


Feature Type Standardized
Nominal ANOVA
mRNA AZD6482 CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA Tamoxifen GDSC1000 pan-cancer AAC 0.11 0.001
mRNA CHIR-99021 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA GSK2636771 CTRPv2 pan-cancer AAC 0.13 0.002
mRNA TGX221 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.1 0.004
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.32 0.005
mRNA PD-0332991 GDSC1000 pan-cancer AAC -0.095 0.006
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.089 0.008
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.085 0.01
Download CSV